Free Trial
NYSE:MED

Medifast (MED) Stock Price, News & Analysis

Medifast logo
$13.97 +0.29 (+2.12%)
Closing price 03:59 PM Eastern
Extended Trading
$14.01 +0.04 (+0.29%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Medifast Stock (NYSE:MED)

Key Stats

Today's Range
$13.50
$14.07
50-Day Range
$13.65
$16.19
52-Week Range
$13.48
$39.00
Volume
152,346 shs
Average Volume
323,803 shs
Market Capitalization
$152.80 million
P/E Ratio
77.61
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Hold

Company Overview

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Remove Ads

Medifast Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

MED MarketRank™: 

Medifast scored higher than 76% of companies evaluated by MarketBeat, and ranked 53rd out of 154 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Medifast has only been the subject of 1 research reports in the past 90 days.

  • Read more about Medifast's stock forecast and price target.
  • Earnings Growth

    Earnings for Medifast are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medifast is 77.61, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.74.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medifast is 77.61, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 16.37.

  • Price to Book Value per Share Ratio

    Medifast has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Medifast's valuation and earnings.
  • Percentage of Shares Shorted

    12.12% of the float of Medifast has been sold short.
  • Short Interest Ratio / Days to Cover

    Medifast has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Medifast has recently decreased by 7.19%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Medifast does not currently pay a dividend.

  • Dividend Growth

    Medifast does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Medifast is 3,666.67%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on EPS estimates, Medifast will have a dividend payout ratio of 431.37% in the coming year. This indicates that Medifast may not be able to sustain their current dividend.

  • Read more about Medifast's dividend.
  • Percentage of Shares Shorted

    12.12% of the float of Medifast has been sold short.
  • Short Interest Ratio / Days to Cover

    Medifast has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Medifast has recently decreased by 7.19%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Medifast has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Medifast this week, compared to 3 articles on an average week.
  • Search Interest

    5 people have searched for MED on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medifast insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.50% of the stock of Medifast is held by insiders.

  • Percentage Held by Institutions

    95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Medifast's insider trading history.
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

MED Stock News Headlines

Medifast management to meet virtually with Stephens
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Medifast Full Year 2024 Earnings: EPS Beats Expectations
Q4 2024 Medifast Inc Earnings Call
Medifast sees Q1 revenue $100M-$120M
Medifast reports Q4 adjusted EPS 10c vs. $1.09 last year
See More Headlines

MED Stock Analysis - Frequently Asked Questions

Medifast's stock was trading at $17.62 on January 1st, 2025. Since then, MED stock has decreased by 20.7% and is now trading at $13.97.
View the best growth stocks for 2025 here
.

Medifast, Inc. (NYSE:MED) issued its quarterly earnings data on Tuesday, February, 18th. The specialty retailer reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.26. The specialty retailer earned $119 million during the quarter, compared to the consensus estimate of $114.25 million. Medifast had a trailing twelve-month return on equity of 10.64% and a net margin of 0.35%.

Top institutional shareholders of Medifast include Renaissance Technologies LLC (8.26%), Federated Hermes Inc. (2.55%), Bank of America Corp DE (2.52%) and Geode Capital Management LLC (2.25%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist.
View institutional ownership trends
.

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
2/18/2025
Today
3/27/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Miscellaneous food preparations & kindred products
Sub-Industry
Personal Products
Current Symbol
NYSE:MED
Employees
870
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.50
High Stock Price Target
$16.50
Low Stock Price Target
$16.50
Potential Upside/Downside
+18.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
77.61
Forward P/E Ratio
27.39
P/E Growth
N/A
Net Income
$99.42 million
Pretax Margin
0.63%

Debt

Sales & Book Value

Annual Sales
$602.46 million
Cash Flow
$2.86 per share
Price / Cash Flow
4.88
Book Value
$19.21 per share
Price / Book
0.73

Miscellaneous

Free Float
10,665,000
Market Cap
$152.80 million
Optionable
Optionable
Beta
1.13

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:MED) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners